Defined Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $502K | Buy |
7,278
+785
| +12% | +$54.2K | 0.31% | 76 |
|
|
2025
Q1 | $451K | Sell |
6,493
-27
| -0.4% | -$1.88K | 0.3% | 77 |
|
|
2024
Q4 | $561K | Sell |
6,520
-16
| -0.2% | -$1.38K | 0.37% | 60 |
|
|
2024
Q3 | $778K | Buy |
6,536
+21
| +0.3% | +$2.5K | 0.51% | 50 |
|
|
2024
Q2 | $930K | Buy |
6,515
+66
| +1% | +$9.42K | 0.65% | 42 |
|
|
2024
Q1 | $828K | Sell |
6,449
-43
| -0.7% | -$5.52K | 0.59% | 45 |
|
|
2023
Q4 | $672K | Buy |
6,492
+106
| +2% | +$11K | 0.51% | 50 |
|
|
2023
Q3 | $581K | Sell |
6,386
-204
| -3% | -$18.6K | 0.5% | 54 |
|
|
2023
Q2 | $533K | Buy |
6,590
+10
| +0.2% | +$809 | 0.45% | 57 |
|
|
2023
Q1 | $524K | Hold |
6,580
| – | – | 0.49% | 52 |
|
|
2022
Q4 | $445K | Buy |
6,580
+260
| +4% | +$17.6K | 0.42% | 66 |
|
|
2022
Q3 | $315K | Buy |
6,320
+70
| +1% | +$3.49K | 0.34% | 67 |
|
|
2022
Q2 | $348K | Sell |
6,250
-100
| -2% | -$5.57K | 0.36% | 67 |
|
|
2022
Q1 | $353K | Hold |
6,350
| – | – | 0.31% | 72 |
|
|
2021
Q4 | $356K | Hold |
6,350
| – | – | 0.29% | 71 |
|
|
2021
Q3 | $305K | Hold |
6,350
| – | – | 0.27% | 79 |
|
|
2021
Q2 | $266K | Hold |
6,350
| – | – | 0.24% | 83 |
|
|
2021
Q1 | $214K | Hold |
6,350
| – | – | 0.2% | 88 |
|
|
2020
Q4 | $222K | Buy |
+6,350
| New | +$222K | 0.22% | 82 |
|